Back to search

Article

Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy Kymriah

2023-07-29

Abstract excerpt

Kymriah is an innovative cancer therapy which works by removing disease fighting T-cells from patients, genetically modifying or reprogramming the immune cells to attack cancer, and re-infusing them back into the patients. It treats childhood blood and bone marrow cancer. The cost of this new hope-giving gene therapy is CHF 450,000 per treatment. This exorbitantly high price set by Novartis, in exercise of its exc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5a45bcd5-fe86-5399-929b-b08739f5f817
DOI
10.2139/ssrn.4525009
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy KymriahDOI 10.2139/ssrn.4525009
Navigating the Pharmaceutical Patent Landscape: Impact of Patent Cliffs on Innovation and AccessibilitySemantic proximity
The Intellectual Property of COVID-19Semantic proximity
Addressing Exclusivity Issues During the COVID-19 Pandemic and BeyondSemantic proximity
Innovation Institutions and COVID-19, Part IISemantic proximity
Bioethical Challenges in the Implementation of Targeted Anti-Tumor Therapies in Low-Resource Settings: A Perspective from Latin AmericaSemantic proximity
Recalibrating Patent Protection for COVID-19 Vaccines: A Path to Affordable Access and Equitable DistributionSemantic proximity
The Role of Intellectual Property Rights on Access to Medicines in the WHO African Region: 25 Years After the TRIPS AgreementSemantic proximity
Beyond Traditional IP: Addressing Regulatory BarriersSemantic proximity
Innovation Institutions and COVID-19Semantic proximity
Patent protection for CRISPR: an ELSI reviewSemantic proximity
§ 1498: A Guide to Government Patent Use, a Path to Licensing and Distributing Generic DrugsSemantic proximity
Avoiding the TRIPS Trap: A Path to Domestic Disclosure of Clinical Drug Data Consistent with International NormsSemantic proximity
Select a neighboring publication to make it the new centre.